Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0U1BU
|
||||
Former ID |
DIB002246
|
||||
Drug Name |
HPP-851
|
||||
Synonyms |
11-beta HSD-1 (metabolic disorders), High Point; 11-beta HSD-1 (metabolic disorders), TransTech Pharma; 11-beta hydroxysteroid dehydrogenase-1 inhibitors (metabolic disorders), Novo Nordisk; 11-beta hydroxysteroid dehydrogenase-1 inhibitors (metabolic disorders), TransTech Pharma
|
||||
Indication | Metabolic disorders [ICD9: 270-279; ICD10:E70-E89] | Preclinical | [548697] | ||
Company |
Novo Nordisk A/S
|
||||
Target and Pathway | |||||
Target(s) | Corticosteroid 11-beta-dehydrogenase, isozyme 1 | Target Info | Inhibitor | [548698] | |
NetPath Pathway | IL1 Signaling Pathway | ||||
FSH Signaling Pathway | |||||
PathWhiz Pathway | Steroidogenesis | ||||
Reactome | Glucocorticoid biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.